{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:17:12Z","timestamp":1783441032733,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.semarthrit.2008.06.004","type":"journal-article","created":{"date-parts":[[2008,8,16]],"date-time":"2008-08-16T11:15:36Z","timestamp":1218885336000},"page":"176-181","source":"Crossref","is-referenced-by-count":47,"title":["Emergence of Crohn's Disease During Treatment with the Anti-Tumor Necrosis Factor Agent Etanercept for Ankylosing Spondylitis: Possible Mechanisms of Action"],"prefix":"10.1016","volume":"39","author":[{"given":"Boulos","family":"Haraoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Krelenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2008.06.004_bib1","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/1529-0131(200112)44:12<2728::AID-ART459>3.0.CO;2-8","article-title":"Inflammatory bowel disease and spondyloarthropathy","volume":"44","author":"Smale","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor\u03b1","volume":"346","author":"Gorman","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib3","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/art.11017","article-title":"Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis","volume":"48","author":"Brandt","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib4","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/art.11104","article-title":"Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis","volume":"48","author":"Braun","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: a randomized placebo-controlled study","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib6","first-page":"294","article-title":"HLA-B27 related arthritis and bowel inflammation","volume":"12","author":"Mielants","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib7","series-title":"The Spondyloarthropathies","first-page":"129","article-title":"The bowel and spondylarthritis: a clinical approach","author":"Mielants","year":"1998"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.berh.2006.03.010","article-title":"Ankylosing spondylitis and bowel disease","volume":"20","author":"Rudelweit","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2008.06.004_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2036.2004.02044.x","article-title":"Review article: joint involvement in inflammatory bowel disease","volume":"20","author":"De Vos","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11926-002-0061-6","article-title":"Gut inflammation and spondyloarthropathies","volume":"4","author":"De Keyser","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib11","series-title":"New onset of Crohn's disease in three patients with ankylosing spondylitis","author":"Song","year":"2006"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/rheumatology\/keh475","article-title":"Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis","volume":"444","author":"Brandt","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib13","first-page":"752","article-title":"Development of Crohn's disease in a patient taking etanercept","volume":"32","author":"Oh","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib14","series-title":"Etanercept and inflammatory bowel disease: friend or foe","author":"Womeldorph","year":"2004"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.62.1.74","article-title":"Efficacy of etanercept for the treatment of Crohn's\u2013related spondyloarthritis but not colitis","volume":"62","author":"Marzo-Ortega","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib16","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/art.11325","article-title":"Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized controlled trial","volume":"48","author":"Davis","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.22669","article-title":"Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor \u03b1 agents","volume":"57","author":"Braun","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0889-857X(05)70042-9","article-title":"Bowel inflammation and the spondyloarthropathies","volume":"24","author":"De Keyser","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib19","first-page":"2279","article-title":"The evolution of spondyloarthropathies in relation to gut histology","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0950-3579(96)80010-0","article-title":"Course of gut inflammation in spondyloarthopathies and therapeutic consequences","volume":"10","author":"Mielants","year":"1996","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib21","series-title":"The Spondyloarthropathies","first-page":"129","article-title":"The bowel and spondylarthritis: a clinical approach","author":"Mielants","year":"1998"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0889-857X(05)70039-9","article-title":"Prognosis, course of disease and treatment of the spondyloarthropathies","volume":"24","author":"Leirisalo-Repo","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/ajcp\/114.3.364","article-title":"Focal up-regulation of E-cahedrin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated lineage","volume":"114","author":"Demetter","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/00365529850171693","article-title":"Distinctive activated cellular subsets in colon from patients with Crohn\u00e8s disease, and ulcerative colitis","volume":"33","author":"Elewaut","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib25","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.4049\/jimmunol.166.7.4650","article-title":"Human leucocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules","volume":"166","author":"Salmi","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/ard.2003.018382","article-title":"Colon mucosa of both spondyloarthritis and Crohn's disease patients is enriched with macrophages expressing the scavenger receptor CD163","volume":"64","author":"Demetter","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/ard.2004.028837","article-title":"CARD15 gene polymorphisms in patients with spondyoarthropathies identify a specific phenotype previously related to Crohn's disease","volume":"64","author":"Laukens","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor \u03b1 for Crohn's disease","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0016-5085(99)70332-X","article-title":"Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease","volume":"117","author":"Rutgeerts","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib31","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1053\/j.gastro.2004.03.076","article-title":"Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease","volume":"126","author":"Kraus","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ard.60.2.133","article-title":"Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNF alpha receptors","volume":"60","author":"Berg","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ard.62.6.561","article-title":"Up regulation of the production of tumor necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept","volume":"62","author":"Zou","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/adc.2003.041046","article-title":"Unravelling the complex genetics of inflammatory bowel disease","volume":"89","author":"Russell","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparison of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1043-4666(03)00201-1","article-title":"The effect of etanercept and infliximab on the production of tumor necrosis factor alpha, interferon gamma and GM-CSF in in vivo activated intestinal T-lymphocytes cultures","volume":"23","author":"Agnholt","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib37","first-page":"86","article-title":"Transmembrane TNF is sufficient to induce localized inflammatory arthritis in transgenic mice","volume":"46","author":"Georgopoulos","year":"1996","journal-title":"J Inflamm"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2036.2005.02309.x","article-title":"Adalumimab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept","volume":"21","author":"Shen","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib39","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/gast.2001.28702","article-title":"Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease using a capsase-dependent pathway","volume":"121","author":"L\u00fcgering","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semarthrit.2008.06.004_bib40","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease","volume":"124","author":"Van den Brande","year":"2003","journal-title":"Gastroenterology"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208001182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208001182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T11:25:24Z","timestamp":1557746724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017208001182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0049017208001182"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2008.06.004","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}